European Archives - Page 65 of 1607 - European Medical Journal

Rethinking Parkinson’s Disease: Interview with Angelo Antonini

For decades, we treated Parkinson’s as if it were strictly an isolated issue in the substantia nigra. But if you actually sit in the clinic…

The ART Conceived Pregnancy: Risks and Evolving Concept

The ART Conceived Pregnancy: Risks and Evolving Concepts

Assisted reproductive technologies (ART) have transformed infertility treatment from a medical intervention into a global standard of…

Mesoglycan Shows Long-Term Promise After Superficial Vein Thrombosis

A clinical trial suggests mesoglycan may reduce long-term recurrence of superficial vein thrombosis, though larger studies are needed to confirm the benefit.

Wildfire Smoke Pollution Linked to Increased Migraines

New research from across a large cohort study in Canada has found that worsened migraine symptoms were associated with particle PM2.5, a component of wildfire smoke.

AstraZeneca's HSCT-TMA drug misses main goal in latest trial

AstraZeneca's HSCT-TMA drug misses main endpoint

A phase 3 trial of ravulizumab fell short in adult HSCT-TMA patients, while paediatric results held more promise.

GLP 1 Receptor Agonists Linked to Hair Loss Risk

A target trial emulation found that glucagon like peptide 1 receptor agonists were associated with a higher risk of non scarring alopecia than two other diabetes drug classes.

Endometrial Immune Profile in Primary Infertility

Women with primary infertility demonstrated significantly higher endometrial levels of the proinflammatory cytokines IL-1β and IL-8 compared…

Gut-Oral Microbiome Changes Linked to Hand Osteoarthritis

A new study has found that oral microbiome dysbiosis and disrupted oral-gut microbial networks were associated with hand osteoarthritis.

Stevens Johnson Syndrome Risk Highest with Lamotrigine

A nationwide cohort quantified Stevens Johnson syndrome and toxic epidermal necrolysis risk after antiseizure medication initiation.

Innovation, Access, and Leadership in Cellular Therapy

Hema Now: Innovation, Access, and Leadership in Cellular Therapy

In this episode of Hema Now, Megan Melody speaks about the evolution of CAR-T cell therapy and its impact on lymphoma care…